loadpatents
name:-0.011726140975952
name:-0.0054910182952881
name:-0.0024490356445312
Baselga; Jose Patent Filings

Baselga; Jose

Patent Applications and Registrations

Patent applications and USPTO patent grants for Baselga; Jose.The latest application filed is for "inhibition of kmt2d for the treatment of cancer".

Company Profile
1.4.9
  • Baselga; Jose - New York NY
  • BASELGA; Jose - Boston MA
  • Baselga; Jose - Barcelona ES
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Inhibition Of Kmt2d For The Treatment Of Cancer
App 20220307031 - Baselga; Jose ;   et al.
2022-09-29
Inhibition of KMT2D for the treatment of cancer
Grant 11,248,229 - Baselga , et al. February 15, 2
2022-02-15
Biomarkers For Determining Responsiveness Of A Cancer To Pi3k Inhibitors
App 20210189503 - VASAN; Neil ;   et al.
2021-06-24
Use Of Phosphoinositide 3-kinase Inhibitors For Treatment Of Vascular Malformations
App 20210060031 - Baselga; Eulalia ;   et al.
2021-03-04
Inhibition Of Kmt2d For The Treatment Of Cancer
App 20190270997 - Baselga; Jose ;   et al.
2019-09-05
Combinations of a PI3K/AKT inhibitor compound with an HER3/EGFR inhibitor compound and use thereof in the treatment of a hyperproliferative disorder
Grant 9,566,334 - Baselga , et al. February 14, 2
2017-02-14
Combinations Of A Pi3k/akt Inhibitor Compound With An Her3/egfr Inhibitor Compound And Use Thereof In The Treatment Of A Hyperproliferative Disorder
App 20150306216 - BASELGA; Jose ;   et al.
2015-10-29
Gene Expression Profiling Of Egfr Positive Cancer
App 20120178644 - Baker; Joffre B. ;   et al.
2012-07-12
Gene expression profiling of EGFR positive cancer
Grant 8,148,076 - Baker , et al. April 3, 2
2012-04-03
Combination Of (a) A Phosphoinositide 3-kinase Inhibitor And (b) An Antidiabetic Compound For Use In The Treatment Of Proliferative Diseases
App 20120059005 - Baselga; Jose ;   et al.
2012-03-08
Gene Expression Profiling of EGFR Positive Cancer
App 20110245102 - Baker; Joffre B. ;   et al.
2011-10-06
Gene expression profiling of EGFR positive cancer
Grant 8,008,003 - Baker , et al. August 30, 2
2011-08-30
Gene expression profiling of EGFR positive cancer
App 20050019785 - Baker, Joffre B. ;   et al.
2005-01-27
Company Registrations
SEC0001601687Baselga Jose

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed